원격 간질 진료 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Tele-Epilepsy Market was valued at USD 571.3 million in 2025 and is estimated to grow at a CAGR of 14.9% to reach USD 2.3 billion by 2035.

Growth in this market is shaped by the increasing prevalence of epilepsy worldwide, the expansion of telehealth reimbursement frameworks, and the accelerated integration of artificial intelligence and Internet of Things technologies into clinical workflows. The care model is shifting away from periodic hospital-based monitoring toward continuous remote supervision supported by wearable biosensors, cloud-based analytics platforms, and AI-enabled seizure detection systems. Healthcare systems across North America, Europe, and Asia Pacific are increasingly adopting tele-epilepsy solutions to reduce hospital readmissions, improve neurologist efficiency, and enhance long-term patient adherence to treatment protocols. This transition is further reinforced by policy-level support in key healthcare markets, including expanded reimbursement frameworks that encourage remote monitoring adoption. As a result, tele-epilepsy is evolving into a core component of modern neurological care delivery rather than a supplementary service, with growing integration into hospital networks, specialized epilepsy centers, and home-based care models.

The software segment accounted for 30% share in 2025, driven by the increasing adoption of AI-powered seizure detection systems, patient monitoring platforms, and clinical decision-support tools embedded within neurological care workflows. Growth in this segment is supported by rising demand for software solutions that integrate seamlessly with electronic health record systems while delivering advanced analytics capable of identifying seizure patterns and supporting clinical decision-making. The continued evolution of artificial intelligence and machine learning capabilities is enabling healthcare providers to monitor larger patient populations remotely without a proportional increase in specialist workforce requirements, thereby improving operational efficiency and care scalability.

The healthcare providers segment held 62.6% share in 2025. This category includes hospitals, specialty neurology centers, clinics, and supervised homecare environments that rely on remote monitoring technologies to manage epilepsy patients. Adoption is being driven by the dual benefits of improved patient outcomes through continuous monitoring and reduced healthcare delivery costs by minimizing in-person consultations and hospital admissions. The increasing willingness of healthcare systems to integrate telehealth solutions into neurology care pathways is reinforcing the long-term adoption of tele-epilepsy platforms across institutional settings.

North America Tele-Epilepsy Market held 42.2% share in 2025. Market expansion is being supported by favorable reimbursement structures that include coverage for remote patient monitoring and chronic disease management services applicable to epilepsy care. Canada is also contributing to regional growth through investments in digital healthcare infrastructure aimed at improving access to neurological care in underserved and remote regions, where specialist availability remains limited.

Major companies operating in the global tele-epilepsy market include BioSerenity SAS, Ceribell, Inc., CortiCare, Inc., Empatica Inc., Epitel, Inc., LivaNova PLC, Medtronic plc, NeuroPace, Inc., Nihon Kohden Corporation, Ovation Healthcare, Philips Healthcare, Real Time Tele-Epilepsy Consultants, Seer Medical, Teladoc Health, Inc., and Vidyo, Inc. Companies operating in the tele-epilepsy market are focusing on technological innovation, platform integration, and strategic collaborations to strengthen their market position. Continuous investment in artificial intelligence, machine learning, and wearable sensor technologies is improving the accuracy and efficiency of seizure detection and patient monitoring systems. Market players are also prioritizing interoperability with electronic health record systems to ensure seamless integration into existing healthcare workflows. Strategic partnerships with hospitals, neurology centers, and telehealth providers are expanding clinical adoption and strengthening service delivery networks.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Market estimates & forecasts parameters
• 1.8 Forecast model
  • 1.8.1 Quantified market impact analysis
    • 1.8.1.1 Mathematical impact of growth parameters on forecast
• 1.9 Research transparency addendum
  • 1.9.1 Source attribution framework
  • 1.9.2 Quality assurance metrics
  • 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
  • 2.1.1 Business trends
  • 2.1.2 Component trends
  • 2.1.3 Epilepsy type trends
  • 2.1.4 Age group trends
  • 2.1.5 End use trends
  • 2.1.6 Regional trends
• 2.2 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of epilepsy
    • 3.2.1.2 Growing demand for remote monitoring services
    • 3.2.1.3 Technological development in telehealth services
    • 3.2.1.4 Rising awareness among patients and caregivers
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Data security and privacy concerns
    • 3.2.2.2 Limited reimbursement policies
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration of AI-driven predictive analytics in epilepsy care
    • 3.2.3.2 Expansion of tele-epilepsy services in emerging markets
• 3.3 Growth potential analysis
• 3.4 Technology and innovation landscape
  • 3.4.1 Current technological trends
  • 3.4.2 Emerging technologies
• 3.5 Pricing trend analysis (Driven by primary research)
• 3.6 Regulatory landscape (Driven by primary research)
  • 3.6.1 North America
  • 3.6.2 Europe
  • 3.6.3 Asia Pacific
  • 3.6.4 Latin America
  • 3.6.5 MEA
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Impact of AI and Generative AI on the market (Driven by primary research)
• 3.11 Investment & funding analysis (Driven by primary research)

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 North America
  • 4.2.2 Europe
  • 4.2.3 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Component, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Software
  • 5.2.1 Cloud-based
  • 5.2.2 On-premises
• 5.3 Services
  • 5.3.1 Tele-consultation services
  • 5.3.2 Tele-monitoring and screening services
  • 5.3.3 Tele-education & training
  • 5.3.4 Other services
• 5.4 Hardware

Chapter 6 Market Estimates and Forecast, By Epilepsy Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Focal seizure
• 6.3 Generalized seizure
• 6.4 Combined seizure

Chapter 7 Market Estimates and Forecast, By Age Group, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Pediatrics
• 7.3 Adults

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Healthcare providers
  • 8.2.1 Hospitals and clinics
  • 8.2.2 Specialized epilepsy centers
  • 8.2.3 Homecare settings
• 8.3 Patients
• 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 France
  • 9.3.3 UK
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 BioSerenity SAS
• 10.2 Ceribell
• 10.3 CortiCare
• 10.4 Empatica
• 10.5 Epitel
• 10.6 LivaNova
• 10.7 Medtronic plc
• 10.8 NeuroPace
• 10.9 Nihon Kohden Corporation
• 10.10 Ovation Healthcare
• 10.11 Philips Healthcare
• 10.12 Real Time Tele-Epilepsy Consultants
• 10.13 Seer Medical
• 10.14 Teladoc Health
• 10.15 Vidyo